Welcome to LookChem.com Sign In|Join Free

CAS

  • or

362621-86-1

Post Buying Request

362621-86-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

362621-86-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 362621-86-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,6,2,6,2 and 1 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 362621-86:
(8*3)+(7*6)+(6*2)+(5*6)+(4*2)+(3*1)+(2*8)+(1*6)=141
141 % 10 = 1
So 362621-86-1 is a valid CAS Registry Number.

362621-86-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name dibenzyl octyl phosphate

1.2 Other means of identification

Product number -
Other names phosphoric Acid dibenzyl ester octyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:362621-86-1 SDS

362621-86-1Downstream Products

362621-86-1Relevant articles and documents

Phospholipid-induced aggregation and anthracene excimer formation

Chen, Kuan-Hung,Yang, Jye-Shane,Hwang, Chung-Yu,Fang, Jim-Min

supporting information; experimental part, p. 4401 - 4404 (2009/05/27)

(Chemical Equation) The zinc complex of anthryl bis(dipicolylamine) (1) aggregates upon binding with long-chain aliphatic phosphates and displays anthracene excimer fluorescence, which provides a new strategy toward detection of the biologically important lysophosphatidic acid in aqueous solution.

LPA receptor agonists and antagonists and methods of use

-

, (2008/06/13)

The present invention relates to compounds according to formula (I) as disclosed herein as well as pharmaceutical compositions which include those compounds. Also disclosed are methods of using such compounds, which have activity as agonists or as antagonists of LPA receptors; such methods including inhibiting LPA activity on an LPA receptor, modulating LPA receptor activity, treating cancer, enhancing cell proliferation, and treating a wound.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 362621-86-1